Stockreport

Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates [Yahoo! Finance]

Editas Medicine, Inc.  (EDIT) 
Last editas medicine, inc. earnings: 2/26 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.editasmedicine.com
PDF Editas Medicine, Inc. Lead candidate, EDIT-401, which demonstrated 90% mean LDL-C reduction in preclinical studies, remains on track for IND/CTA submission by mid-202 [Read more]